Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | SMMT | IONS | ||
| Company | Neurocrine Bioscienc | Summit Therapeu ADR | Ionis Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.74 | 17.30 | 73.64 | ||
| High | 133.99 | 18.79 | 75.92 | ||
| Low | 131.53 | 17.20 | 73.45 | ||
| Latest | 132.64 | 18.84 | 75.11 | ||
| Change | +3.92 | +1.86 | +2.59 | ||
| % Change | +3.05% | +10.95% | +3.57% | ||
| Volume | 389,681 | 1,996,006 | 876,945 | ||
| 20-Day Average Volume | 948,786 | 2,532,527 | 2,400,762 | ||
| Previous Close | 128.72 | 16.98 | 72.52 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 129.74 | 16.13 | 73.19 | ||
| 20-Day Raw Stochastic | 76.23% | 99.51% | 55.26% | ||
| 20-Day Relative Strength | 51.64 | 61.91 | 48.12 | ||
| Weighted Alpha | +24.57 | +14.28 | +101.13 | ||
| Today's Opinion | 56% Sell | 8% Sell | 24% Buy | ||
| Previous Opinion | 88% Sell | 24% Sell | 8% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.64% since 03/24/26 | +20.33% since 03/24/26 | +7.74% since 03/24/26 | ||
| Low | 128.02 on 03/27/26 | 15.84 on 03/25/26 | 70.50 on 03/26/26 | ||
| High | 133.74 on 03/31/26 | 18.72 on 03/31/26 | 75.89 on 03/31/26 | ||
| 1-Month | |||||
| %Chg | +0.20% since 02/27/26 | +12.72% since 02/27/26 | -7.49% since 02/27/26 | ||
| Low | 125.11 on 03/24/26 | 14.60 on 03/06/26 | 68.90 on 03/24/26 | ||
| High | 134.83 on 03/04/26 | 18.72 on 03/31/26 | 82.75 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -8.77% since 12/26/25 | +3.09% since 12/26/25 | -6.08% since 12/26/25 | ||
| Low | 122.14 on 02/12/26 | 13.83 on 02/05/26 | 68.90 on 03/24/26 | ||
| High | 145.51 on 12/29/25 | 20.20 on 01/09/26 | 86.74 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | -6.68% since 09/26/25 | -10.74% since 09/26/25 | +17.13% since 09/26/25 | ||
| Low | 122.14 on 02/12/26 | 13.83 on 02/05/26 | 63.36 on 09/29/25 | ||
| High | 160.18 on 12/08/25 | 25.49 on 10/13/25 | 86.74 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,918,724 | 13,165,832 | 11,979,724 | ||
| Shares Outstanding, K | 100,363 | 775,373 | 165,192 | ||
| Annual Sales | 2,860,500,000 | 0 | 943,710,000 | ||
| Annual Net Income | 478,600,000 | -1,079,590,000 | -381,390,000 | ||
| Last Quarter Sales | 805,500,000 | 0 | 203,330,000 | ||
| Last Quarter Net Income | 153,700,000 | -219,170,000 | -229,390,000 | ||
| 60-Month Beta | 0.32 | -1.43 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.88 on 02/11/26 | -0.29 on 02/23/26 | -1.14 on 02/25/26 | ||
| Latest Earnings Date | 05/04/26 | 05/07/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 27.84 | 0.00 | 0.00 | ||